# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-011260
Filing Date
2020-03-17
Accepted
2020-03-16 20:46:40
Documents
68
Period of Report
2019-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | nvus-10k_20191231.htm | 10-K | 2375794
2 | EX-4.4 | nvus-ex44_576.htm | EX-4.4 | 21682
3 | EX-21.1 | nvus-ex211_11.htm | EX-21.1 | 3373
4 | EX-23.1 | nvus-ex231_451.htm | EX-23.1 | 11306
5 | EX-23.2 | nvus-ex232_452.htm | EX-23.2 | 4831
6 | EX-31.1 | nvus-ex311_9.htm | EX-31.1 | 11344
7 | EX-31.2 | nvus-ex312_6.htm | EX-31.2 | 11487
8 | EX-32.1 | nvus-ex321_12.htm | EX-32.1 | 7078
9 | EX-32.2 | nvus-ex322_10.htm | EX-32.2 | 7104
10 | GRAPHIC | gmsxlai2fp3t000001.jpg | GRAPHIC | 2613
11 | GRAPHIC | gdnwj3iwx32g000001.jpg | GRAPHIC | 25790
12 | GRAPHIC | gdnwj3iwx32g000002.jpg | GRAPHIC | 14552
| Complete submission text file | 0001564590-20-011260.txt |  | 7476351

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL INSTANCE DOCUMENT | nvus-20191231.xml | EX-101.INS | 1430623
14 | XBRL TAXONOMY EXTENSION SCHEMA | nvus-20191231.xsd | EX-101.SCH | 60826
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nvus-20191231_cal.xml | EX-101.CAL | 51204
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nvus-20191231_def.xml | EX-101.DEF | 162969
17 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nvus-20191231_lab.xml | EX-101.LAB | 437018
18 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nvus-20191231_pre.xml | EX-101.PRE | 322654

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36620 | Film No.: 20718988
SIC: 2834 Pharmaceutical Preparations